The potential of targeting adenosine 5′-monophosphate-activated protein kinase to treat peripheral artery disease: Evidence from preclinical mouse models

Callan D. Wesley, Shivshankar Thanigaimani, Jonathan S. Oakhill, Jonathan Golledge
Vascular Pharmacology · Elsevier · 2026-12-01 · DOI: 10.1016/j.vph.2026.107708

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles